SecBot SecBot
3 ·Filed Apr 1, 2026

ASND

Ascendis Pharma A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001610717-26-000138
Form 3, initial insider ownership statement
Actionable Insight • Neutral

No trading action warranted; monitor future Form 4 filings for actual buying or selling activity by Bienaime or other insiders, which could signal sentiment shifts

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$229.25
T+0 close · Apr 1, 2026 · via day close
Latest settled
+16.34%
T+60 · $266.72
Vs SPY
+2.18%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 2 $229.25entry
  2. T+1 · 7mo ago −1.12%α −1.59% · $226.69
  3. T+5 · 7mo ago +4.38%α +0.76% · $239.28
  4. T+20 · 7mo ago +0.06%α −9.82% · $229.38
  5. T+60 · 5mo ago +16.34%α +2.18% · $266.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jean-Jacques Bienaime, a director or significant insider of Ascendis Pharma, filed a Form 3 to report initial beneficial ownership of 9,160 ordinary shares and 172.35 warrants exercisable into shares, with a power of attorney granted to several executives to file SEC reports on his behalf. This is a routine initial filing for ownership disclosure and does not indicate any change in holdings or strategic direction.

Key Facts

  • Jean-Jacques Bienaime filed Form 3 to report initial beneficial ownership as of March 23, 2026
  • He holds 9,160 ordinary shares (including ADSs) and 172.35 warrants
  • Warrants vest 25% on June 10, 2026, then in 36 equal monthly installments through 2035
  • Power of attorney granted to six company executives, including CEO, CFO, and CLO, to file SEC forms on his behalf
  • Filing is administrative and related to compliance, not a transaction or material event

Financial Impact

No immediate financial impact, ownership levels are small (9,160 shares in a $14.2B company) and no transactions reported

insider ownershipshare countdilution

Risk Factors

  • Minimal risk, this is a standard disclosure with no operational or financial implications
  • Potential misinterpretation of warrant vesting schedule as near-term dilution, though amounts are negligible

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001610717-26-000138
Document: 0001610717-26-000138-index-headers.html0001610717-26-000138
Document: 0001610717-26-000138-index.html0001610717-26-000138
Document: 0001610717-26-000138.txt0001610717-26-000138

Track record

41 reports on ASND

Performance horizon

14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 24 of 27 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.09 −0.32% settles Feb 12
  2. Nov 12, 20263d ago 6-K Neutral 2/10 Entry $267.07 Now $271.09 +1.51% settles Feb 11
  3. Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.09 +1.51% settles Feb 10
  4. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.09 +1.51% settles Feb 10
  5. Nov 6, 20269d ago 6-K Bullish 6/10 Entry $259.85 Now $271.09 +4.33% settles Feb 5
  6. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.09 +5.56% settles Feb 4
  7. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.09 +6.96% settles Feb 3
  8. Nov 2, 202613d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.09 +8.36% settles Feb 1
  9. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.09 +10.27% settles Jan 25
  10. Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.09 +20.35% settles Jan 13
Showing 10 of 41

US Market Status

Market Open · Closes in 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026